Registry of Lobbyists
| Subject matters | Details | Categories |
|---|---|---|
|
Health, Industry
|
Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, with respect to ensuring that the life sciences sector is a major focus of the government’s post-COVID recovery plan.
|
Policies or Program
|
|
Health, Industry
|
Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s plans for the creation of new biomanufacturing capacity for Canada.
|
Policies or Program
|
|
Health
|
Engagement with officials regarding Health Canada’s proposed development of a strategy for drugs for rare disorders and other aspects of national pharmacare, including proposals for a Canada Drug Agency and a national formulary.
|
Policies or Program
|
|
Health, Industry
|
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
|
Regulation, Policies or Program
|
|
Health
|
Health Canada Regulations Amending the Patented Medicines Regulations (Additional Factors and Information Reporting Requirements) (SOR/2019-298) published in the Canada Gazette Part 2 on August 21, 2019.
|
Regulation
|
Address:
109-1 Concorde Gate
Toronto, ON M3C 3N6
Canada
Telephone number:
416-426-7293
Web address:
www.lifesciencesontario.ca
Jason Field, President & CEO
Life Sciences Ontario is not a subsidiary of any other parent companies.
Life Sciences Ontario is not a coalition.
Life Sciences Ontario does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Stephanie Levee | Public offices held
Firm: 3Sixty Public Affairs Inc.